Epidermal Growth Factor Receptor Inhibitor Database
|
|
|
|
|
|
|
|
|
|
|
| Molecule List | |||
| S.No | Molecule Id | ErbB2 IC50 | |
| 301. | EGIN0001116 | 42 nM | |
| 302. | EGIN0001117 | 7 nM | |
| 303. | EGIN0001118 | 173 nM | |
| 304. | EGIN0001119 | 25 nM | |
| 305. | EGIN0001120 | 95 nM | |
| 306. | EGIN0001121 | 435 nM | |
| 307. | EGIN0001122 | 6 nM | |
| 308. | EGIN0001225 | 25-50 nM | |
| 309. | EGIN0001229 | 25-50 nM | |
| 310. | EGIN0001236 | 45000± 4300 nM | |
| 311. | EGIN0001237 | 12100± 2200 nM | |
| 312. | EGIN0001238 | 9400 ± 400 nM | |
| 313. | EGIN0001239 | 35000 nM | |
| 314. | EGIN0001239 | 33000 ± 5000 nM | |
| 315. | EGIN0001239 | 35000 nM | |
| 316. | EGIN0001240 | >500000 nM | |
| 317. | EGIN0001240 | 22000 ± 6000 nM | |
| 318. | EGIN0001240 | >500000 nM | |
| 319. | EGIN0001241 | 18000 nM | |
| 320. | EGIN0001241 | 20000± 3500 nM | |
| 321. | EGIN0001242 | 2900± 300 nM | |
| 322. | EGIN0001243 | 62000 ± 7000 nM | |
| 323. | EGIN0001244 | >166000 nM | |
| 324. | EGIN0001244 | 20000± 1500 nM | |
| 325. | EGIN0001245 | 34000 nM | |
| 326. | EGIN0001245 | 44000± 13000 nM | |
| 327. | EGIN0001246 | 21 ± 6 nM | |
| 328. | EGIN0001247 | 17000 nM | |
| 329. | EGIN0001247 | 19000 ± 3000 nM | |
| 330. | EGIN0001248 | 130 nM | |
| 331. | EGIN0001248 | 130 ± 7 nM | |
| 332. | EGIN0001249 | 450 nM | |
| 333. | EGIN0001249 | 450± 70 nM | |
| 334. | EGIN0001250 | 1650 nM | |
| 335. | EGIN0001250 | 1650± 190 nM | |
| 336. | EGIN0001251 | 200 nM | |
| 337. | EGIN0001251 | 200 ± 30 nM | |
| 338. | EGIN0001252 | 15000 nM | |
| 339. | EGIN0001252 | 350 nM | |
| 340. | EGIN0001252 | 350± 70 nM | |
| 341. | EGIN0001253 | 1500 nM | |
| 342. | EGIN0001253 | 6100± 100 nM | |
| 343. | EGIN0001289 | 776 nM | |
| 344. | EGIN0001290 | 100 nM | |
| 345. | EGIN0001291 | 1530 nM | |
| 346. | EGIN0001292 | >100000 nM | |
| 347. | EGIN0001293 | 10000 nM | |
| 348. | EGIN0001294 | 10000 nM | |
| 349. | EGIN0001295 | >100000 nM | |
| 350. | EGIN0001296 | >100000 nM | |
| First Previous Next Last | Page:7 out of :26 |
| TOP |